文献速递造血干细胞移植与细胞治疗淋巴瘤

单倍体造血干细胞移植后EB病毒激活患者早期细胞免疫耗竭的研究

[Early cellular immune exhaustion in patients with Epstein-Barr virus activation following haploidentical hematopoietic stem cell transplantation].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2024-01-01

本研究纳入23例接受单倍体造血干细胞移植的患者,比较移植后发生EBV激活(EBV+组9例)与未激活(EBV-组14例)患者移植后1、2、3个月NK细胞、T细胞和B细胞免疫重建及耗竭标志物表达和杀伤功能的差异。结果显示EBV+组存在NK细胞与T淋巴细胞重建延迟、耗竭分子高表达及杀伤功能减弱,这些因素可能与移植后EBV激活相关。

要点

  • 移植后1个月EBV+组CD3(+)CD8(+) T细胞中位比例低于EBV-组(P=0.033)。
  • EBV+组CD3(+)CD8(+) T细胞上TIM-3表达水平高于EBV-组(P=0.009)。
  • 移植后1个月EBV+组CD3(+)CD8(+) T和CD3(+)CD4(+) T细胞颗粒酶B中位阳性率低于EBV-组(P=0.033、P=0.016)。

核心结论

  • 单倍体HSCT后NK细胞与T淋巴细胞重建延迟、耗竭分子高表达及杀伤功能减弱可能与移植后EBV激活相关。

研究设计与样本

  • 纳入23例接受单倍体造血干细胞移植的患者,比较移植后发生EBV激活(EBV+组)与未激活(EBV-组)患者移植后1、2、3个月的NK细胞、T细胞和B细胞免疫重建及NK细胞和T细胞耗竭标志物(PD-1、TIM-3、CTLA-4)表达水平及杀伤功能差异。

主要发现

  • EBV+组9例,均为EBV血症,未发生EBV相关终末器官疾病;EBV-组14例,两组基线临床特征差异均无统计学意义。
  • 移植后1个月EBV+组CD3(+)CD8(+) T细胞中位比例低于EBV-组(P=0.033);移植后2个月EBV+组CD3(-)CD16(neg)CD56(bri) NK细胞亚群中位比例高于EBV-组(P=0.046)。
  • 移植后1、2、3个月两组间CD3(-)CD19(+) B细胞中位比例差异均无统计学意义。
  • 移植后1个月EBV+组CD3(-)CD16(bri)CD56(dim) NK细胞亚群上CTLA-4表达水平高于EBV-组(P=0.033),EBV+组CD3(+)CD8(+) T细胞上TIM-3表达水平高于EBV-组(P=0.009)。
  • 移植后2个月EBV+组CD3(-)CD16(neg)CD56(dim) NK细胞亚群上TIM-3表达水平低于EBV-组(P=0.023);移植后1、3个月EBV+组CD3(+)CD4(+) T细胞上TIM-3表达水平均高于EBV-组(P=0.002、P=0.043)。

关键数值与推荐

  • 移植后1个月EBV+组CD3(+)CD8(+) T和CD3(+)CD4(+) T细胞表达颗粒酶B的中位阳性率低于EBV-组(P=0.033、P=0.016)。
  • 移植后2个月EBV+组CD3(-)CD16(bri)CD56(neg)细胞亚群表达颗粒酶B的中位阳性率高于EBV-组(P=0.012);EBV+组CD3(+)CD4(+) T细胞表达颗粒酶B中位阳性率低于EBV-组(P=0.049)。
  • 移植后3个月EBV+组CD3(-)CD16(bri)CD56(dim)细胞亚群表达穿孔素的中位阳性率高于EBV-组(P=0.003);EBV+组CD3(+)CD8(+) T细胞表达IFN-γ中位阳性率低于EBV-组(P=0.036)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: This study aimed to investigate the association between early immune reconstitution and Epstein-Barr virus (EBV) reactivation by analyzing changes in natural killer (NK), B, and T cells and their functional status in the peripheral blood during the early post-transplant period. Methods: This study included 23 patients who underwent haplo-hematopoietic stem cell transplantation (HSCT). The immune reconstitution of NK cells, T cells, and B cells as well as the expression levels of NK and T cell exhaustion markers (PD-1, TIM-3, and CTLA-4) and cytotoxic function at 1, 2, and 3 months post-transplantation were compared between patients with EBV activation (EBV+ group) and those without activation (EBV- group) post- transplantation. Results: EBV activation occurred in nine patients post-transplantation (EBV+ group), whereas 14 patients demonstrated no activation (EBV- group). All patients with EBV activation exhibited EBV viremia, and no EBV-associated diseases occurred. No significant differences in the clinical characteristics were found between the two groups of patients. The median proportion of CD3(+)CD8(+) T cells in the EBV+ group was significantly lower than that in the EBV- group at 1 month post-transplantation (P=0.033). The median proportion of the CD3(-)CD16(neg)CD56(bri) subset in the EBV+ group was significantly higher than that in the EBV- group at 2 months post-transplantation (P=0.046). No significant differences in the median proportions of CD3(-)CD19(+) B cells were observed between the two groups at 1, 2, and 3 months post-transplantation. The expression of CTLA-4 on CD3(-)CD16(bri)CD56(dim) NK cells in the EBV+ group was significantly higher than that in the EBV- group at 1 month post-transplantation (P=0.033). The expression of TIM-3 on CD3(+)CD8(+) T cells in the EBV+ group was significantly higher than that in the EBV- group (P=0.009). The expression level of TIM-3 on CD3(-)CD16(neg)CD56(dim) NK cells in the EBV+ group was significantly lower than that in the EBV- group at 2 months post-transplantation (P=0.023). The expression levels of TIM-3 on CD3(+)CD4(+) T cells in the EBV+ group than those in the EBV- group at 1 and 3 months post-transplantation (P=0.002, P=0.043). The median positive rate of Granzyme B expression in CD3(+)CD8(+) T cells and CD3(+)CD4(+) T cells in the EBV+ group was significantly lower than that in the EBV- group at 1-month post-transplantation (P=0.033, P=0.016). The median positive rate of Granzyme B expression in the CD3(-)CD16(bri)CD56(neg) cell subset in the EBV+ group was higher than that in the EBV- group at 2 months post-transplantation (P=0.012). The median positive rate of Granzyme B expression in CD3(+)CD4(+) T cells in the EBV+ group remained significantly lower than that in the EBV- group at 2 months post-transplantation (P=0.049). The median positive rate of perforin expression in the CD3(-)CD16(bri)CD56(dim) cell subset was significantly higher in the EBV+ group than in the EBV- group at 3 months post-transplantation (P=0.003). The median positive rate of IFN-γ expression in CD3(+)CD8(+) T cells in the EBV+ group was significantly lower than that in the EBV- group at 3 months post-transplantation (P=0.036) . Conclusion: Delayed NK cell and T lymphocyte reconstitution, high exhaustion marker expression, and weakened cytotoxic functions may be related to EBV reactivation after haploidentical HSCT. 目的: 本研究通过检测单倍体造血干细胞移植(HSCT)后早期外周血NK细胞、T细胞和B细胞亚群及功能变化情况,探讨移植早期免疫重建与EB病毒(EBV)激活的关联。 方法: 纳入23例接受单倍体HSCT患者,比较移植后发生EBV激活(EBV+组)与未激活(EBV-组)患者移植后1、2、3个月的NK细胞、T细胞和B细胞免疫重建情况以及NK细胞和T细胞耗竭标志物(PD-1、TIM-3、CTLA-4)的表达水平及其杀伤功能的差异。 结果: EBV+组9例,均为EBV血症,未发生EBV相关终末器官疾病;EBV-组14例。两组患者基线临床特征差异均无统计学意义。移植后1个月EBV+组CD3(+)CD8(+) T细胞中位比例低于EBV-组(P=0.033);移植后2个月EBV+组患者CD3(-)CD16(neg)CD56(bri) NK细胞亚群中位比例高于EBV-组(P=0.046);移植后1、2、3个月两组间CD3(-)CD19(+) B细胞中位比例差异均无统计学意义。移植后1个月EBV+组CD3(-)CD16(bri)CD56(dim) NK细胞亚群上CTLA-4的表达水平高于EBV-组(P=0.033),EBV+组CD3(+)CD8(+) T细胞上TIM-3的表达水平高于EBV-组(P=0.009);移植2个月EBV+组CD3(-)CD16(neg)CD56(dim) NK细胞亚群上TIM-3的表达水平低于EBV-组(P=0.023);移植后1、3个月EBV+组CD3(+)CD4(+) T细胞上TIM-3的表达水平均高于EBV-组(P=0.002、P=0.043)。移植后1个月EBV+组CD3(+)CD8(+) T和CD3(+)CD4(+) T细胞表达颗粒酶B的中位阳性率低于EBV-组(P=0.033、P=0.016);移植后2个月EBV+组CD3(-)CD16(bri)CD56(neg)细胞亚群表达颗粒酶B的中位阳性率高于EBV-组(P=0.012);EBV+组CD3(+)CD4(+) T细胞表达颗粒酶B中位阳性率低于EBV-组(P=0.049);移植后3个月EBV+组CD3(-)CD16(bri)CD56(dim)细胞亚群表达穿孔素的中位阳性率高于EBV-组(P=0.003);EBV+组CD3(+)CD8(+) T细胞表达IFN-γ中位阳性率低于EBV-组(P=0.036)。 结论: 单倍体HSCT后NK细胞与T淋巴细胞重建延迟、耗竭分子高表达及杀伤功能减弱可能与移植后EBV激活相关。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Huang YF, Zhang SY, He JB, et al. [Early cellular immune exhaustion in patients with Epstein-Barr virus activation following haploidentical hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 39746692. doi:10.3760/cma.j.cn121090-20240825-00322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。